Harvard researchers have gleaned a clue as to how one of the most devastating and mysterious neurodegenerative diseases eventually causes patients to lose control of the ability to walk, speak, and breathe -- suggesting a possible new approach for developing drugs. Kevin Eggan, professor of stem cell and regenerative biology at the Harvard Stem Cell Institute, led the research.
News & Research
